T1	DISO 61 91	carcinoma de células escamosas
#1	AnnotatorNotes T1	C0007137; Squamous cell carcinoma; Neoplastic Process
T2	CHEM 958 974	ingenol mebutato
#2	AnnotatorNotes T2	C2825682; ingenol mebutate; Organic Chemical · Pharmacologic Substance
T3	DISO 100 121	neoplasias de la piel
#3	AnnotatorNotes T3	C0037286; Skin Neoplasms; Neoplastic Process
T4	DISO 139 159	queratosis actínicas
#4	AnnotatorNotes T4	C0022602; Actinic keratosis; Neoplastic Process
T5	DISO 161 176	manchas solares
#5	AnnotatorNotes T5	C0016689; Freckles; Finding
T6	PROC 178 186	tratados
#6	AnnotatorNotes T6	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T7	PROC 210 217	placebo
#7	AnnotatorNotes T7	C0032042; Placebos; Therapeutic or Preventive Procedure
T8	DISO 254 284	carcinoma de células escamosas
#8	AnnotatorNotes T8	C0007137; Squamous cell carcinoma; Neoplastic Process
T9	PROC 788 795	tratado
#9	AnnotatorNotes T9	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T10	DISO 293 314	neoplasias de la piel
#10	AnnotatorNotes T10	C0037286; Skin Neoplasms; Neoplastic Process
T11	DISO 332 352	queratosis actínicas
#11	AnnotatorNotes T11	C0022602; Actinic keratosis; Neoplastic Process
T12	CHEM 362 378	ingenol disoxato
#12	AnnotatorNotes T12	C5139830; Ingenol disoxate; Organic Chemical · Pharmacologic Substance
T13	CHEM 405 413	vehículo
#13	AnnotatorNotes T13	C0042444; Drug vehicle; Biomedical or Dental Material
T14	PROC 415 428	Ensayo fase 3
#14	AnnotatorNotes T14	C0282461; Phase 3 Clinical Trial; Research Activity
T15	DISO 461 484	carcinoma escamocelular
T16	DISO 493 514	neoplasias de la piel
#15	AnnotatorNotes T16	C0037286; Skin Neoplasms; Neoplastic Process
T17	ANAT 534 538	piel
#16	AnnotatorNotes T17	C1123023; Skin; Body System | C1278993; Entire skin; Body System
T18	CHEM 559 575	ingenol disoxato
#17	AnnotatorNotes T18	C5139830; Ingenol disoxate; Organic Chemical · Pharmacologic Substance
T19	CHEM 582 590	vehículo
#18	AnnotatorNotes T19	C0042444; Drug vehicle; Biomedical or Dental Material
T20	DISO 600 620	queratosis actínicas
#19	AnnotatorNotes T20	C0022602; Actinic keratosis; Neoplastic Process
T21	ANAT 627 631	cara
#20	AnnotatorNotes T21	C0015450; Face; Body Location or Region | C1281591; Entire face; Body Location or Region
T22	ANAT 633 638	pecho
#21	AnnotatorNotes T22	C0817096; Chest; Body Location or Region | C1269614; Entire thorax; Body Part, Organ, or Organ Component
T23	ANAT 641 656	cuero cabelludo
#22	AnnotatorNotes T23	C0036270; Scalp structure; Body Part, Organ, or Organ Component | C1278997; Entire scalp; Body Part, Organ, or Organ Component
T24	DISO 680 695	Manchas solares
#23	AnnotatorNotes T24	C0016689; Freckles; Finding
T25	DISO 722 741	Queratosis Actínica
#24	AnnotatorNotes T25	C0022602; Actinic keratosis; Neoplastic Process
T26	PROC 942 953	tratamiento
#25	AnnotatorNotes T26	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T27	PROC 1008 1019	tratamiento
#26	AnnotatorNotes T27	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T28	ANAT 74 91	células escamosas
#27	AnnotatorNotes T28	C0221910; Squamous Epithelial Cells; Cell
T29	ANAT 117 121	piel
#28	AnnotatorNotes T29	C1123023; Skin; Body System | C1278993; Entire skin; Body System
T30	CHEM 977 993	ingenol disoxato
#29	AnnotatorNotes T30	C5139830; Ingenol disoxate; Organic Chemical · Pharmacologic Substance
T31	CHEM 187 203	ingenol disoxato
#30	AnnotatorNotes T31	C5139830; Ingenol disoxate; Organic Chemical · Pharmacologic Substance
T32	ANAT 267 284	células escamosas
#31	AnnotatorNotes T32	C0221910; Squamous Epithelial Cells; Cell
T33	ANAT 310 314	piel
#32	AnnotatorNotes T33	C1123023; Skin; Body System | C1278993; Entire skin; Body System
T34	PROC 353 361	tratados
#33	AnnotatorNotes T34	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T35	ANAT 510 514	piel
#34	AnnotatorNotes T35	C1123023; Skin; Body System | C1278993; Entire skin; Body System
T36	PROC 539 547	tratadas
#35	AnnotatorNotes T36	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T37	Date 13 17	2017
T38	LIVB 125 134	pacientes
#36	AnnotatorNotes T38	C0030705; Patients; Patient or Disabled Group
T39	Form 204 207	gel
#37	AnnotatorNotes T39	C0017243; Gel; Biomedical or Dental Material
T40	LIVB 318 327	pacientes
#38	AnnotatorNotes T40	C0030705; Patients; Patient or Disabled Group
T41	Form 379 382	gel
#39	AnnotatorNotes T41	C0017243; Gel; Biomedical or Dental Material
T42	Dose 383 392	al 0,018%
T43	Form 552 555	gel
#40	AnnotatorNotes T43	C0017243; Gel; Biomedical or Dental Material
T44	Form 578 581	gel
#41	AnnotatorNotes T44	C0017243; Gel; Biomedical or Dental Material
T45	LIVB 771 779	paciente
#42	AnnotatorNotes T45	C0030705; Patients; Patient or Disabled Group
T46	LIVB 924 932	paciente
#43	AnnotatorNotes T46	C0030705; Patients; Patient or Disabled Group
T47	Dose 395 401	0,037%
T48	PROC 869 875	visita
#44	AnnotatorNotes T48	C1512346; Patient Visit; Health Care Activity
T49	Quantifier_or_Qualifier 876 878	11
A1	Status T9 History_of
#45	AnnotatorNotes T15	C0007137; Squamous cell carcinoma; Neoplastic Process
R1	Experiences Arg1:T45 Arg2:T9	
R2	Has_Quantifier_or_Qualifier Arg1:T48 Arg2:T49	
T50	PROC 854 862	evaluado
#46	AnnotatorNotes T50	C1261322; Evaluation procedure; Health Care Activity
R3	Overlap Arg1:T50 Arg2:T48	
R4	Experiences Arg1:T45 Arg2:T50	
T51	Observation 788 817	tratado en uno de los ensayos
R5	Experiences Arg1:T45 Arg2:T51	
A2	Status T50 History_of
R6	Before Arg1:T9 Arg2:T50	
R7	Before Arg1:T9 Arg2:T48	
R8	Location_of Arg1:T28 Arg2:T1	
R9	Location_of Arg1:T29 Arg2:T3	
R10	Experiences Arg1:T38 Arg2:T1	
R11	Experiences Arg1:T38 Arg2:T3	
R12	Experiences Arg1:T38 Arg2:T4	
R13	Experiences Arg1:T38 Arg2:T5	
R14	Overlap Arg1:T1 Arg2:T4	
R15	Overlap Arg1:T1 Arg2:T5	
R16	Overlap Arg1:T3 Arg2:T4	
R17	Overlap Arg1:T3 Arg2:T5	
R18	Experiences Arg1:T38 Arg2:T6	
R19	Used_for Arg1:T31 Arg2:T6	
R20	Has_Drug_Form Arg1:T31 Arg2:T39	
R21	Experiences Arg1:T38 Arg2:T7	
R22	Location_of Arg1:T32 Arg2:T8	
R23	Location_of Arg1:T33 Arg2:T10	
R24	Experiences Arg1:T40 Arg2:T8	
R25	Experiences Arg1:T40 Arg2:T10	
R26	Experiences Arg1:T40 Arg2:T11	
R27	Overlap Arg1:T10 Arg2:T11	
R28	Overlap Arg1:T8 Arg2:T11	
R29	Experiences Arg1:T40 Arg2:T34	
R30	Used_for Arg1:T12 Arg2:T34	
R31	Has_Drug_Form Arg1:T12 Arg2:T41	
R32	Has_Dose_or_Strength Arg1:T12 Arg2:T42	
R33	Has_Dose_or_Strength Arg1:T12 Arg2:T47	
R34	Used_for Arg1:T13 Arg2:T34	
R35	Location_of Arg1:T35 Arg2:T16	
R36	Location_of Arg1:T17 Arg2:T36	
R37	Used_for Arg1:T18 Arg2:T36	
R38	Has_Drug_Form Arg1:T18 Arg2:T43	
R39	Has_Drug_Form Arg1:T19 Arg2:T44	
R40	Used_for Arg1:T19 Arg2:T36	
R41	Location_of Arg1:T21 Arg2:T20	
R42	Location_of Arg1:T22 Arg2:T20	
R43	Location_of Arg1:T23 Arg2:T20	
R44	Location_of Arg1:T22 Arg2:T36	
R45	Location_of Arg1:T23 Arg2:T36	
R46	Location_of Arg1:T21 Arg2:T36	
R47	Experiences Arg1:T46 Arg2:T26	
R48	Used_for Arg1:T2 Arg2:T26	
R49	Used_for Arg1:T30 Arg2:T26	
T52	CONC 1000 1019	área de tratamiento
R50	Location_of Arg1:T52 Arg2:T26	
R51	Used_for Arg1:T2 Arg2:T27	
R52	Used_for Arg1:T30 Arg2:T27	
R53	Location_of Arg1:T17 Arg2:T15	
R54	Location_of Arg1:T35 Arg2:T15	
R55	Overlap Arg1:T15 Arg2:T20	
R56	Overlap Arg1:T16 Arg2:T20	
A3	Experiencer T38 Patient
A4	Experiencer T40 Patient
A5	Experiencer T45 Patient
A6	Experiencer T46 Patient
